Boehringer ingelheim rejects new merger advances

摘要

Germany's largest privately owned drug manufacturer Boehringer Ingelheim has rejected recent M & A advances by undisclosed major German and Swiss companies and plans to stay independent, said CFO Marbod Muff earlier this month at the firm's annual financial results meeting.